Wolfgang Wurst 

  •                                 
    Extbase Variable Dump
    'distribution:BiomSpeaker.html' (29 chars)
    
                            
  •                                     
    Extbase Variable Dump
    'fileadmin/Webdata/Uploads/Veranstaltungen/2025/BayOConnect_2025/Speaker/Wurs
     t_300x300.jpg    ' (89 chars)
    
                                
  •                                     
    Extbase Variable Dump
    'Wolfgang Wurst' (14 chars)
    
                                
  •                                     
    Extbase Variable Dump
    'Emeritus Helmholtz Munich; Expert on Scientific Networking and Entrepreneurs
     hip    ' (79 chars)
    
                                
  •                                     
    Extbase Variable Dump
    'Prof. Dr. Wolfgang Wurst (Emeritus) of Excellence was Director of the Instit
     ute of Developmental Genetics (IDG) at the Helmholtz Zentrum München (HMGU) 
     in Neuherberg and chair-holder at the Technical University Munich (TUM) unti
     l December 2024. Since September 2009 he was also Partner of the DZNE (Germa
     n Centre of Neurodegenerative Diseases), Site Munich, Germany.<br />Before h
     e was appointed to his current positions at HMGU and TUM in 2002, he was gro
     up leader of the group ‘Molecular Neurogenetics’ at the Max-Planck-Institute
      of Psychiatry in Munich and Junior Research Group Leader at the Department 
     of Mammalian Genetics, Helmholtz Munich. Prof. Dr. Wurst studied Biology/Che
     mistry at the University of Freiburg, Germany, obtained his PhD (summa cum l
     aude) at the University of Göttingen, Germany, in 1988, and continued with p
     ost-doctoral training at the University Göttingen (1988-1989) and the Samuel
      Lunefeld Research Institute of the Mount Sinai Hospital, Division of Molecu
     lar and Developmental Biology, Toronto, Canada (1989-1994; headed by Prof. A
     . Joyner).<br />He has longstanding expertise in the development and applica
     tion of novel gene editing technologies for in vivo gene function annotation
      (gene trapping, gene targeting, RNA Interference, TAL-effector nucleases, Z
     inc-finger-nucleases, CRISPR/Cas) and therapeutic applications (somatic gene
      repair). In this context he was among others coordinator of the European Co
     nditional Mouse Mutagenesis Program (EUCOMM/EUCOMMTools) and is founding mem
     ber of the International Mouse Knockout Consortium (IKMC) of which he was pr
     esident in 2010/11.<br />Furthermore, he focuses on the generation and analy
     sis of new human cellular and tissue models as well as animal models for neu
     rological (Dementias, Parkinson’s disease, ALS) and psychiatric diseases (Ma
     jor depression).    ' (1840 chars)